Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.

van den Brink MR, Moore E, Horndasch KJ, Crawford JM, Murphy GF, Burakoff SJ.

Transplantation. 2000 Jul 15;70(1):184-91.

PMID:
10919598
2.

Fas-deficient lpr mice are more susceptible to graft-versus-host disease.

van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ.

J Immunol. 2000 Jan 1;164(1):469-80.

6.

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T, Ferrara JL, Burakoff SJ, van den Brink MR.

Blood. 2001 May 1;97(9):2886-95.

9.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
10.

Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

Maeda Y, Levy RB, Reddy P, Liu C, Clouthier SG, Teshima T, Ferrara JL.

Blood. 2005 Mar 1;105(5):2023-7. Epub 2004 Oct 5.

11.

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.

Schmaltz C, Alpdogan O, Muriglan SJ, Kappel BJ, Rotolo JA, Ricchetti ET, Greenberg AS, Willis LM, Murphy GF, Crawford JM, van den Brink MR.

Blood. 2003 Mar 15;101(6):2440-5. Epub 2002 Nov 7.

12.
13.

A major role for the Fas pathway in acute graft-versus-host disease.

Via CS, Nguyen P, Shustov A, Drappa J, Elkon KB.

J Immunol. 1996 Dec 15;157(12):5387-93.

PMID:
8955186
14.

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA.

J Immunol. 2000 Nov 1;165(9):4901-9.

15.

Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.

Maeda Y, Reddy P, Lowler KP, Liu C, Bishop DK, Ferrara JL.

Blood. 2005 Jul 15;106(2):749-55. Epub 2005 Mar 29.

16.

Role of CXCR3-induced donor T-cell migration in acute GVHD.

Duffner U, Lu B, Hildebrandt GC, Teshima T, Williams DL, Reddy P, Ordemann R, Clouthier SG, Lowler K, Liu C, Gerard C, Cooke KR, Ferrara JL.

Exp Hematol. 2003 Oct;31(10):897-902.

PMID:
14550805
17.

Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.

Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE.

J Immunol. 1996 Dec 1;157(11):4811-21.

PMID:
8943383
18.
Items per page

Supplemental Content

Write to the Help Desk